Parvovirus B19 Infection Studies
Parvovirus B19 Infection Studies is a research topic within Infectious Diseases. Science Explorer counts 23k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the infection, pathogenesis, and clinical implications of Parvovirus B19, particularly in the context of fetal hydrops, autoimmune diseases, and pregnancy complications. It also explores viral transmission, persistence in immunocompetent and immunocompromised individuals, and the association with various hematological and rheumatic disorders.
- Parvovirus B19
- Fetal Hydrops
- Autoimmune Disease
- Erythrovirus
- Intrauterine Infection
- Viral Pathogenesis
- Nonimmune Hydrops Fetalis
- Pregnancy Complications
- Immunocompromised Host
- Viral Transmission
- Research works
- 23k fractional, since 1950
- In the world top 10%
- 2.3k per year above
- Top-10% rate
- 10.1% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +0% the tick is no change
- Largest producer
United States
34% of the 10 largest, 2022-now
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Parvovirus B19 Infection Studies research?
By volume, the United States and India publish the most (751 and 316 works in 2022-now).
By volume, 2022-now
- 1
United States 751 works
- 2
India 316 works
- 3
China 313 works
- 4
Japan 150 works
- 5
Brazil 137 works
- 6
Italy 126 works
- 7
France 110 works
- 8
United Kingdom 107 works
- 9
Germany 105 works
- 10
Spain 93 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Parvovirus B19 Infection Studies research?
By volume in 2022-now, Harvard University publishes the most Parvovirus B19 Infection Studies research, followed by All India Institute of Medical Sciences and Capital Medical University.
By volume, 2022-now
- 1
Harvard University
United States 26 works
- 2
All India Institute of Medical Sciences
India 23 works
- 3
Capital Medical University
China 16 works
- 4
Inserm
France 15 works
- 5
Cornell University
United States 15 works
- 6
Université Paris Cité
France 14 works
- 7
Post Graduate Institute of Medical Education and Research
India 14 works
- 8
National Institutes of Health
United States 13 works
- 9
Baylor College of Medicine
United States 13 works
- 10
Mayo Clinic
United States 13 works
Who are the leading researchers in Parvovirus B19 Infection Studies?
The most-cited researchers publishing on Parvovirus B19 Infection Studies include Jun Wang, Giuseppe Remuzzi and Matthias Egger.
- 1
Jun Wang
China 340k citations
- 2
Giuseppe Remuzzi
Italy 328k citations
- 3
Matthias Egger
Switzerland 326k citations
- 4
Gregory Y.H. Lip
United Kingdom 311k citations
- 5
Richard A. Gibbs
United States 292k citations
- 6
Hagop M. Kantarjian
United States 273k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Parvovirus B19 Infection Studies research done?
The largest centres of Parvovirus B19 Infection Studies research in 2022-now are Beijing (China), Paris (France), London (United Kingdom) and New York (United States).
Where is the best place to study Parvovirus B19 Infection Studies?
Among universities, judged by research, Harvard University, Cornell University and Capital Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Parvovirus B19 Infection Studies, country by countryIs Parvovirus B19 Infection Studies research growing?
Output in 2022-2025 was 0% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Parvovirus B19 Infection Studies.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Parvovirus B19 Infection Studies as a percentage of every work published that year, 0.014% in 2024.
Fractional works of Parvovirus B19 Infection Studies over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Parvovirus B19 Infection Studies. Posts are plain text and can be reported.